Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia, Inc. (symbol: PHR) is a leading provider of comprehensive software solutions designed to enhance the operational and financial performance of healthcare organizations. Through its innovative SaaS-based technology platform, Phreesia enables medical groups of all sizes to streamline their administrative, financial, and clinical operations, thereby allowing healthcare staff to focus more on delivering exceptional patient care.
The Phreesia Platform offers a robust suite of integrated solutions that manage various aspects of patient interactions. These solutions include patient access, registration, payments, and clinical support, all aimed at optimizing patient health outcomes. By activating patients in their care, Phreesia ensures that healthcare providers can offer more personalized and efficient services.
Phreesia's flexible and scalable platform is trusted by leading healthcare organizations to revolutionize their point of service. The platform encompasses a wide range of technologies and services, from initial patient contact and registration to appointment scheduling, payment processing, and post-appointment patient surveys. This comprehensive range of services drives tangible results, enhancing both patient and provider experiences.
Recent achievements and current projects at Phreesia include continuous updates to their software to ensure compatibility with the latest technological advancements and regulatory requirements. The company also focuses on forming strategic partnerships that further enhance the capabilities of their platform.
In terms of financial condition, Phreesia has shown consistent growth, driven by the increasing demand for efficient healthcare management solutions. The company's ability to adapt to the evolving needs of the healthcare industry makes it a significant player in the market.
Phreesia, Inc. (NYSE: PHR) announced it will release its fiscal Q1 2024 financial results on May 31, 2023, after market close. A press release and stakeholder letter will be available on the investor website. Following this, a conference call is scheduled for the same day at 5 PM ET to discuss the financial results. Phreesia is recognized for its patient activation solutions and enabled over 120 million patient visits in 2022, which represents over 10% of U.S. patient visits.
Unlimited Systems and Phreesia have announced a partnership to integrate their services, enhancing patient experience in oncology practices. This collaboration will allow independent oncology practices to utilize Phreesia's patient-driven intake tools, offering mobile check-in and automated appointment reminders. Notably, practices using Phreesia have reported that 69% of patients self-check-in, saving over 5 minutes per visit, and 86% have had insurance verified before appointments. The integration aims to reduce staff burdens and improve operational efficiencies through features like real-time insurance verification and streamlined workflows.
Phreesia, Inc. (NYSE: PHR) has appointed Balaji Gandhi as its new Chief Financial Officer, effective March 24, 2023. Gandhi, who has over 25 years of experience in healthcare services and technology, joined Phreesia in 2019 and has served as Senior Vice President of Investor Relations. He succeeds Randy Rasmussen, who will assist in the transition as a Strategic Advisor. CEO Chaim Indig emphasized Gandhi's deep understanding of the company and his successful communication with the investment community, aiming to drive long-term value for stakeholders.
Phreesia, Inc. (NYSE: PHR) reported fiscal fourth quarter and year results ending January 31, 2023, showcasing significant growth yet persistent net losses. Q4 revenue reached $76.6 million, a 32% increase YOY, with a total annual revenue of $280.9 million, also up 32%. The average number of healthcare services clients (AHSCs) grew 36% YOY to 3,140, though healthcare services revenue per AHSC fell 4%. A net loss of $38.0 million marks an improvement from $46.5 million last year. Despite cash reserves of $176.7 million, net losses expanded to $176.1 million for FY 2023. For FY 2024, Phreesia forecasts revenue between $353 million and $356 million.
Phreesia has announced that Alexandra Beneville, Vice President of Life Sciences Content Strategy, has been named to MM+M's 2023 'Women to Watch' class, recognizing her as one of 18 influential women in the healthcare marketing field. Since joining Phreesia in August, Beneville has significantly impacted the company's Life Sciences strategy and operations, driving growth and enhancing diversity and inclusion. Phreesia, listed on the NYSE under the symbol PHR, focuses on empowering life sciences companies through tailored patient interactions and insights.
FAQ
What is the current stock price of Phreesia (PHR)?
What is the market cap of Phreesia (PHR)?
What does Phreesia, Inc. do?
What is the Phreesia Platform?
How does Phreesia benefit healthcare organizations?
What are some of Phreesia's recent achievements?
What makes Phreesia's platform scalable and flexible?
Who uses Phreesia's services?
What is Phreesia's approach to patient activation?
How does Phreesia enhance patient-provider interactions?
What are some key features of the Phreesia Platform?
How is Phreesia performing financially?
